Development of Classification Model batteries for predicting inhibition of tubulin polymerization by small molecules
暂无分享,去创建一个
Thomas L. James | Anna Maria Bianucci | Marcello Imbriani | Ilaria Massarelli | Tiziana Mundula | A. Bianucci | T. James | M. Imbriani | I. Massarelli | Tiziana Mundula
[1] T. Tsuruo,et al. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. , 1996, Cancer research.
[2] T. Yamori,et al. Synthesis and Biological Evaluation of Boronic Acid Containing cis‐Stilbenes as Apoptotic Tubulin Polymerization Inhibitors , 2006, ChemMedChem.
[3] R. Gambari,et al. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. , 2006, Journal of medicinal chemistry.
[4] P. Renard,et al. Novel benzopyridothiadiazepines as potential active antitumor agents. , 2005, Journal of medicinal chemistry.
[5] D. Kingston,et al. Syntheses and bioactivities of macrocyclic paclitaxel bis-lactones. , 2004, Bioorganic & medicinal chemistry.
[6] S. Kasibhatla,et al. Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. Part 1: structure-activity relationships of the 4-anilino group. , 2006, Bioorganic & medicinal chemistry.
[7] G. Giannini,et al. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. , 2005, Journal of medicinal chemistry.
[8] Y. Koiso,et al. Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. , 1998, Bioorganic & medicinal chemistry letters.
[9] V. Villalobos,et al. Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin. , 2000, Bioorganic & medicinal chemistry.
[10] A. Brossi,et al. Antitumor agents. Part 226: synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters. , 2003, Bioorganic & medicinal chemistry letters.
[11] Andrea Brancale,et al. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies. , 2006, Journal of medicinal chemistry.
[12] Yoav Freund,et al. The Alternating Decision Tree Learning Algorithm , 1999, ICML.
[13] João Aires-de-Sousa,et al. Prediction of enantioselectivity using chirality codes and Classification and Regression Trees , 2005 .
[14] S. Mooberry,et al. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. , 1999, Cancer research.
[15] P. Corchete,et al. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. , 2007, Bioorganic & medicinal chemistry letters.
[16] E. Hamel,et al. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. , 1988, Molecular pharmacology.
[17] A. Tropsha,et al. Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis. , 2000, Journal of medicinal chemistry.
[18] Weikang Tao,et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. , 2005, Cancer cell.
[19] Concepción Pérez-Melero,et al. New naphthylcombretastatins. Modifications on the ethylene bridge. , 2005, Bioorganic & medicinal chemistry.
[20] E. Günther,et al. Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides , 2004, Archiv der Pharmazie.
[21] Alessandro Pedretti,et al. VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming , 2004, J. Comput. Aided Mol. Des..
[22] H. Hsieh,et al. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. , 2007, Journal of medicinal chemistry.
[23] Mathias Schmidt,et al. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[24] T. Barlozzari,et al. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. , 1995, Cancer research.
[25] S. Ng,et al. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. , 2001, Cancer research.
[26] D. Sackett,et al. Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives. , 2008, Bioorganic & Medicinal Chemistry Letters.
[27] R. Peláez,et al. A new family of quinoline and quinoxaline analogues of combretastatins. , 2004, Bioorganic & medicinal chemistry letters.
[28] Robert D. Clark,et al. OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets , 1997, J. Chem. Inf. Comput. Sci..
[29] A. Brossi,et al. Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors. , 1998, Journal of medicinal chemistry.
[30] Anna Ivana Scovassi,et al. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies. , 2007, Journal of medicinal chemistry.
[31] Y. Hitoshi,et al. R-253 Disrupts Microtubule Networks in Multiple Tumor Cell Lines , 2006, Clinical Cancer Research.
[32] S. Kuo,et al. Synthesis and Biological Evaluation of 6 , 7 , 2 ′ , 3 ′ , 4 ′-Substituted-1 , 2 , 3 , 4-tetrahydro-2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents , 1998 .
[33] William E. Kemnitzer,et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. , 2004, Journal of medicinal chemistry.
[34] P Willett,et al. Comparison of algorithms for dissimilarity-based compound selection. , 1997, Journal of molecular graphics & modelling.
[35] H. Harn,et al. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. , 2006, Biochemical pharmacology.
[36] Scott D. Kahn,et al. Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.
[37] Geoff Holmes,et al. Multiclass Alternating Decision Trees , 2002, ECML.
[38] H. Hsieh,et al. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. , 2006, Journal of medicinal chemistry.
[39] A. Malikzay,et al. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines. , 2006, Bioorganic & medicinal chemistry letters.
[40] T. Owa,et al. Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis. , 2002, Molecular cancer therapeutics.
[41] Igor V. Tetko,et al. Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..
[42] Igor V Tetko,et al. Computing chemistry on the web. , 2005, Drug discovery today.
[43] Thomas G. Dietterich. An Experimental Comparison of Three Methods for Constructing Ensembles of Decision Trees: Bagging, Boosting, and Randomization , 2000, Machine Learning.
[44] G. Jasso. Review of "International Encyclopedia of Statistical Sciences, edited by Samuel Kotz, Norman L. Johnson, and Campbell B. Read, New York, Wiley, 1982-1988" , 1989 .
[45] Andrea Brancale,et al. Arylthioindoles, potent inhibitors of tubulin polymerization. , 2004, Journal of medicinal chemistry.
[46] Y. Kuo,et al. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. , 2004, Molecular pharmacology.
[47] A. Mannschreck,et al. Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives. , 1997, Journal of medicinal chemistry.
[48] F. Mollinedo,et al. Microtubules, microtubule-interfering agents and apoptosis , 2003, Apoptosis.
[49] J. Doroshow,et al. Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel , 2004, Clinical Cancer Research.
[50] Brian D. Hudson,et al. Parameter Based Methods for Compound Selection from Chemical Databases , 1996 .
[51] M. Boyd,et al. Antineoplastic agents. 379. Synthesis of phenstatin phosphate. , 1998, Journal of medicinal chemistry.
[52] E. De Clercq,et al. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles. , 2005, Bioorganic & medicinal chemistry letters.
[53] F. Mollinedo,et al. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. , 2005, Journal of medicinal chemistry.
[54] B. Sikic,et al. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] Osman A. B. S. M. Gani,et al. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. , 2008, Bioorganic & medicinal chemistry.
[56] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[57] S. Thoret,et al. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10. , 1998, Bioorganic & medicinal chemistry letters.
[58] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[59] J. Wdzieczak‐Bakala,et al. New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. , 2008, Journal of medicinal chemistry.
[60] S. Srivastava,et al. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents. , 2007, Journal of medicinal chemistry.
[61] Desire L. Massart,et al. Classification and Regression Trees-Studies of HIV Reverse Transcriptase Inhibitors , 2004, J. Chem. Inf. Model..
[62] M. Jordan,et al. Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.
[63] Jeffrey R. Jackson,et al. Targeted anti-mitotic therapies: can we improve on tubulin agents? , 2007, Nature Reviews Cancer.
[64] G. Klebe,et al. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. , 2006, Journal of medicinal chemistry.
[65] A K Chakraborti,et al. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. , 1991, Journal of medicinal chemistry.
[66] Yvan Vander Heyden,et al. Classification Tree Models for the Prediction of Blood-Brain Barrier Passage of Drugs , 2006, J. Chem. Inf. Model..
[67] S. Kasibhatla,et al. Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay. , 2003, Journal of medicinal chemistry.
[68] A. Brancale,et al. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization. , 2008, Bioorganic & medicinal chemistry letters.
[69] Austin J. Peck,et al. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. , 2004, Biochemistry.
[70] S. Steinberg,et al. Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] Deepak Sampath,et al. Preclinical Pharmacologic Evaluation of MST-997, an Orally Active Taxane with Superior In vitro and In vivo Efficacy in Paclitaxel- and Docetaxel-Resistant Tumor Models , 2006, Clinical Cancer Research.
[72] Gordon M. Crippen,et al. Use of Classification Regression Tree in Predicting Oral Absorption in Humans , 2004, J. Chem. Inf. Model..
[73] T. Fojo,et al. Tubulin/microtubules: still a promising target for new chemotherapeutic agents. , 2000, Journal of the National Cancer Institute.
[74] C. Fairchild,et al. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). , 1998, Cancer research.
[75] A. Bianucci,et al. Quantitative Structure–Activity Relationship Models for Predicting Biological Properties, Developed by Combining Structure‐ and Ligand‐Based Approaches: An Application to the Human Ether‐a‐go‐go‐Related Gene Potassium Channel Inhibition , 2009, Chemical biology & drug design.
[76] D L Massart,et al. Classification of drugs in absorption classes using the classification and regression trees (CART) methodology. , 2005, Journal of pharmaceutical and biomedical analysis.
[77] F. Meng,et al. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles. , 2007, Journal of medicinal chemistry.
[78] Y. Koiso,et al. Ustiloxins, new antimitotic cyclic peptides: interaction with porcine brain tubulin. , 1995, Biochemical pharmacology.
[79] Ramaswamy Nilakantan,et al. Database diversity assessment: New ideas, concepts, and tools , 1997, J. Comput. Aided Mol. Des..
[80] Peter Schmidt,et al. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. , 2007, Journal of medicinal chemistry.
[81] N. Lawrence,et al. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.
[82] H. Hsieh,et al. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. , 2004, Journal of medicinal chemistry.
[83] H. Rosenkranz,et al. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. , 1996, Bioorganic & medicinal chemistry.